Metformin's contraindications should be contraindicated

被引:60
作者
McCormack, J
Johns, K
Tildesley, H
机构
[1] St Pauls Hosp, Div Endocrinol, Vancouver, BC V6Z 1Y6, Canada
[2] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
10.1503/cmaj.045292
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this first of 2 commentaries, James McCormack and coauthors present their view on whether the current contraindications to metformin therapy are warranted for certain patients with type 2 diabetes. We sent the article, which arrived unsolicited, out for peer review and received a particularly thoughtful assessment from George Fantus, who weighed some of the same evidence and reached a different conclusion ( see page 505). We thought you might find it as interesting as we did to read 2 careful considerations of the same clinical question that reach different answers. Evidence, at least for this issue, is in the eye of the beholder.
引用
收藏
页码:502 / 504
页数:3
相关论文
共 23 条
[1]   METFORMIN-INDUCED LACTIC-ACIDOSIS IN PRESENCE OF ACUTE RENAL-FAILURE [J].
ASSAN, R ;
HEUCLIN, C ;
GANEVAL, D ;
BISMUTH, C ;
GEORGE, J ;
GIRARD, JR .
DIABETOLOGIA, 1977, 13 (03) :211-217
[2]   Lactic acidosis rates in type 2 diabetes [J].
Brown, JB ;
Pedula, K ;
Barzilay, J ;
Herson, MK ;
Latare, P .
DIABETES CARE, 1998, 21 (10) :1659-1663
[3]   Evaluation of prescribing practices - Risk of lactic acidosis with metformin therapy [J].
Calabrese, AT ;
Coley, KC ;
DaPos, SV ;
Swanson, D ;
Rao, RH .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (04) :434-437
[4]  
*CAN PHARM ASS, 2001, COMP PHARM SPEC
[5]   Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (04) :486-494
[6]  
Ellis A K, 2001, Can J Clin Pharmacol, V8, P104
[7]   Contraindications to metformin therapy in patients with Type 2 diabetes - a population-based study of adherence to prescribing guidelines [J].
Emslie-Smith, AM ;
Boyle, DIR ;
Evans, JMM ;
Sullivan, F ;
Morris, AD .
DIABETIC MEDICINE, 2001, 18 (06) :483-488
[8]   Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies [J].
Hanefeld, M ;
Cagatay, M ;
Petrowitsch, T ;
Neuser, D ;
Petzinna, D ;
Rupp, M .
EUROPEAN HEART JOURNAL, 2004, 25 (01) :10-16
[9]   Contra-indications to metformin therapy are largely disregarded [J].
Holstein, A ;
Nahrwold, D ;
Hinze, S ;
Egberts, EH .
DIABETIC MEDICINE, 1999, 16 (08) :692-696
[10]   A risk-benefit assessment of metformin in type 2 diabetes mellitus [J].
Howlett, HCS ;
Bailey, CJ .
DRUG SAFETY, 1999, 20 (06) :489-503